PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
25/06/2026
Voltar para busca
Dado oficial do USPTO
INHATARGET
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
INHATARGET
ST13
US500000088312441Classe
1, 5, 10, 42
Pedido
88312441
Registro
6005331
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42
Data de depósito
22/02/2019
Data de registro
10/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2020
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Bruxelles, BE
Examinador
EULIN, INGRID C
Localização atual
Historical data usage
Titulares e representantes
Titulares
U. B. (pessoa física)
Representantes
Clifford D. Hyra Fresh IP PLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and chemical compositions for use in manufacturing medical preparations
Classe 5
Pharmaceutical and veterinary preparations for the treatment of respiratory diseases and disorders; Chemicals and chemical preparations for medical and veterinary useall for administration to human or animal patientschemical reagents for medical or veterinary purposes; Pharmaceutical preparations for pulmonary administrationpharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparations for inhalationinhaled pharmaceuticals for the treatment of respiratory diseases and disorders; Powders for inhalerspharmaceutical preparation of inhalation for the treatment of asthma; Powders for asthma inhalerspowder preparation for the treatment of asthma; Powders for transdermal injectionpharmaceutical preparation for use in treating respiratory diseases and disorders; Pharmaceutical and veterinary preparations for oral ingestionpharmaceutical preparation for the treatment of respiratory diseases and disorders through oral ingestion; Pharmaceuticals and veterinary preparations for local administrationmedicated preparations for the treatment of respiratory diseases and disorders
Classe 10
Medical and veterinary apparatusarticles and aidsall for the administration of pharmaceutical preparations to human or animal patientsmedical instruments for use in treating respiratory diseases and disorderssurgical instruments and apparatuscatheter for veterinary purposes; Pharmaceutical preparation administration aidsmedical apparatus for introducing pharmaceutical preparations into the human body; devices for applying medicineinhalators sold empty; Inhalers for medical purposes sold empty; Dry powder inhalers for medical purposessold empty; Inhalers for treating asthmanebulizer for administering medication in the form of a mist inhaled into the lungsfor treatment of asthmaparts and fittings for all the aforesaid goods
Classe 42
Scientific research and development with respect to pharmaceutical preparationsapparatus and aids for administering medicines; designdevelopment and laboratory testing of new pharmaceutical productsapparatus and aids for administering medicines; Medical and pharmaceutical research services; research in the field of medical administration apparatus and aids; Research in relation to medicine formulationresearch and development of vaccines and medicines; Research and development in the field of pharmaceuticals; product safety testing with respect to medical and pharmaceutical administration apparatus and aids; testing of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/06/2026
ES8R
TEAS SECTION 8 RECEIVED
10/03/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2019
PUBO
PUBLISHED FOR OPPOSITION
24/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
15/11/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2019
ALIE
ASSIGNED TO LIE
04/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2019
GNRT
NON-FINAL ACTION E-MAILED
04/05/2019
CNRT
NON-FINAL ACTION WRITTEN
04/05/2019
DOCK
ASSIGNED TO EXAMINER
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/03/2019
NWAP
NEW APPLICATION ENTERED
26/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INHATARGET ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.